source
- Endpoints Weekly releases 2026 Women in Biopharma list of 20 honorees after reviewing 200 nominationsEndpoints Weekly announced its annual Women in Biopharma 2026 project, highlighting leading women in the industry. The editorial team examined close to 200 nominations to select a shortlist. The…
- Parkinson’s-focused Aspen and bispecific biotech Bambusa plan IPOsParkinson’s disease cell therapy-focused Aspen Neuroscience and bispecific biotech Bambusa Therapeutics are the latest drug developers to eye up a public listing.Fierce Biotech · 10d ago↗ source
- Hengrui secures $15.2 billion Bristol Myers deal and pivots to co-development with Western partners